englishslovensky
  • Šebová Katarína, Fridrichová Ivana: Epigenetic tools in potential anti-cancer therapy. Anti-cancer drugs 21, p. 565-577, 2010  [PubMed]
  • Šebová Katarína, Zmetáková Iveta, Bella Vladimír, Kajo Karol, Stankovičová Iveta, Kajabová Viera, Krivulčík Tomáš, Lasabová Zora, Tomka Miroslav, Galbavý Štefan, Fridrichová Ivana: RASSF1A and CDH1 hypermethylation as potential epimarkers in breast cancer.. Cancer Biomarkers 10, p. 13-26, 2012  [PubMed]  [DOI]
  • Kajabová Viera, Smolková Božena, Zmetáková Iveta, Šebová Katarína, Krivulčík Tomáš, Bella Vladimír, Kajo Karol, Macháleková Katarína, Fridrichová Ivana: RASSF1A Promoter Methylation Levels Positively Correlate with Estrogen Receptor Expression in Breast Cancer Patients. Translational Oncology 6, p. 297-304, 2013  [DOI]

Valid HTML 4.01 Transitional